Medication-overuse Headache: The Effect of a Patient Educational Programme as an add-on to Standard Treatment
Medication-overuse Headache: The Effect of a Patient Educational Programme as an add-on to Standard Treatment
The aim of this study is to evaluate the influence of personality profiles in patients with
 MOH and to evaluate the effect of a custom-made educational programme as an add-on to
 standard treatment as compared to standard treatment alone in MOH patients using a randomized
 controlled trial (RCT) design.
Worldwide, two percent of the population suffers from medication-overuse headache (MOH), a
 paradox condition where the headache is caused by overuse of headache medication. Common
 treatment is withdrawal, but there is no consensus on what constitutes the best treatment.

 The study consists of a RCT with MOH patients randomized to standard treatment versus
 standard treatment + a 12-week, 6-session educational programme as add-on. The programme is
 based on theory of motivational interviewing, and patients can choose between individualized
 education or education in groups.

 Primary endpoint: Headache frequency measured by self-reported headache diary on number of
 days with headache pre-vious month. Secondary endpoints: NEO-FFI-3 personality test, coping
 strategies, pain intensity, bothersomeness, patient satis-faction and reported medication
 intake.
Inclusion Criteria:

 -  Diagnosed with medication-overuse headache (MOH) by neurologist (The International
 Classification of headache Disorders).

 -  Completed withdrawal (hospitalized of 8 days or at home).

 -  Age 18-65 years

 -  Understand and speak Danish

 Exclusion Criteria:

 -  Comorbidity (e.g. whiplash, rheumatism which needs analgesic treatment

 -  Mental health disorders